Brian Delin

Brian Delin is currently the Stock Administration Manager at Neurocrine Biosciences since November 2021. Prior to this role, Brian served as the Sr. Global Stock Plan Manager at Incyte from July 2016 to November 2021, overseeing the company's equity compensation plans for over 2,100 employees across 15 countries and ensuring compliance with global security and tax regulations. Brian's extensive experience includes roles at organizations such as Kelly Services, FIS, SunGard, Shire, Teleflex, and Vanguard, focusing on stock plan administration and benefits analysis. Brian holds an M.B.A. in Finance from Saint Joseph's University and a B.A. in Business Administration and Finance from Ursinus College.